Canadian Pharma, Biotech and Life Sciences Stocks

MedX Health has tons of upside, says Beacon Securities

Beacon Securities analyst Doug Cooper thinks the market has so far ignored a series of recent game-changing announcements by medical technology company MedX Health (MedX Health Stock Quote, Chart, News TSXV:MDX). That scenario, said Cooper in a June 16 update to clients, makes for a prime investmen ...

Profound Medical is insulated from COVID-19, says Raymond James

Looking for bright spots within the ongoing market deluge? Raymond James analyst Rahul Sarugaser says Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) should be top of mind, as the company appears to be well-insulated with respect to the COVID-19 pandemic. In an update to client ...

CRH Medical has price target cut at Beacon Securities

CRH Medical Corporation (CRH Medical Corporation Stock Quote, Chart, News TSX:CRH) hung onto its “Buy” rating from Beacon Securities analyst Doug Cooper after disappointing fourth quarter results. The analyst reviewed the Q4 in an update to clients on Thursday and reduced his target by half. Va ...

There’s still upside to Aurinia Pharma, says Mackie Research

All eyes are on a 2021 launch of voclosporin, lead candidate from drug developer Aurinia Pharmaceuticals (Aurinia Pharma Stock Quote, Chart, News NASDAQ:AUPH), but the stock received a target price trim from analyst André Uddin of Mackie Research on Friday, going from $24.00 to $22.00 per share. V ...

Oncolytics Biotech is “dramatically undervalued”, says Echelon Wealth

Alberta-based biologics developer Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TSX:ONC) has a clear roster of clinical milestones ahead for its flagship virus formulation, according to Echelon Wealth Partners analyst Doug Loe, who reviewed the company’s quarterly results and ge ...

Profound Medical is a Raymond James Best Pick for 2020

In his words, Raymond James analyst Rahul Sarugaser is expecting “massive recurring revenue” coming from Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) once the commercialization of its TULSA-PRO medical device really picks up steam. In a review of the company’s latest q ...

Theratechnologies new CEO gets thumbs up at Mackie Research

After a passing of the torch to a new CEO for Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH), analyst André Uddin of Mackie Research is sticking with his assessment of the company, saying in an update to clients on Monday that at these prices the stock is a bargain. Montreal ...

Q4 2019 Share Price Performance

Q4 2019 Share Price Performance Healthcare Stocks Surge  In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 4Q-2019, and provides commentary on select stock movements and overall market trends.  Inclusion Criteria  Our ana ...

Centric Health is one of my top picks: Stephen Takacsy

Centric Health (Centric Health Stock Quote, Chart, News TSX:CHH) is one beaten up stock you might want to look at. The healthcare company had been mired in debt for a number of years but has recently made moves to right the ship, says Stephen Takacsy of Lester Asset Management, who calls Centric a ...

Three reasons to buy Theratechnologies from Mackie Research

Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH) after its latest quarterly results. The analyst reviewed Theratechnologies fourth quarter in a report to clients on Tuesday and reiterated his ...